AST Revolution, LLC (AST Revolution) has announced its official launch following the recent completion of a court-approved acquisition of select assets of Accelerate Diagnostics, Inc. (Accelerate) under the Chapter 11 process. As part of the transaction, AST Revolution acquired the Accelerate WAVE™ and Arc™ Systems and associated intellectual property portfolio, establishing a dedicated platform to advance next-generation rapid antimicrobial susceptibility testing (AST). AST Revolution will be led by Lawrence Mertz, former Chief Technology Officer of Accelerate. AST Revolution is backed by controlling shareholder Indaba Capital Management, L.P. (Indaba Capital), a San Francisco-based investment firm.
Read the full article: AST Revolution, LLC Launches Following Acquisition of Accelerate Diagnostics Assets //
Source: https://www.businesswire.com/news/home/20250916636863/en/AST-Revolution-LLC-Launches-Following-Acquisition-of-Accelerate-Diagnostics-Assets